Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02872077 · ClinicalTrials.gov registry record · NA

Efficacy of Auricular Acupuncture on Neonatal Abstinence Syndrome

A NA study, sponsored by University of South Florida.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT02872077: Completed NA study, sponsored by University of South Florida.

NCT02872077 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02872077, a NA study, has completed, sponsored by University of South Florida.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

This study will assess the efficacy of needle auricular acupuncture (AA) in neonatal abstinence syndrome (NAS) infants who require pharmacologic therapy at the Tampa General Hospital NICU. The investigators will evaluate efficacy of needle AA as an adjunct treatment for NAS by means of total methadone dose exposure, peak withdrawal scores, and overall length of stay. This is the first study to evaluate efficacy of needle AA as an adjunct treatment for NAS by means of total methadone dose exposure, peak withdrawal scores, and overall length of stay.

Interventions

  • OTHER Auricular acupuncture

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2016-08
Est. Completion 2018-10-09
Phase NA
University of South Florida

252 total trials

What the finished NCT02872077 record still lists

NCT02872077 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Auricular acupuncture is the first listed.

NCT02872077 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02872077 about?

NCT02872077 is a clinical study titled "Efficacy of Auricular Acupuncture on Neonatal Abstinence Syndrome". This study will assess the efficacy of needle auricular acupuncture (AA) in neonatal abstinence syndrome (NAS) infants who require pharmacologic therapy at the Tampa General Hospital NICU. The investigators will evaluate efficacy of needle AA as an adjunct treatment for NAS by means of total methado...

What is the current status of trial NCT02872077?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2016-08. Estimated completion is 2018-10-09.

What interventions are being tested in trial NCT02872077?

The interventions under investigation include: Auricular acupuncture (OTHER).

Who is sponsoring clinical trial NCT02872077?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02872077's enrollment target sits among peer trials

26 1710th of 2000 higher than 289 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02872077, the US trial registry maintained by the National Library of Medicine. NCT02872077 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.